Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider James Garner purchased 39,500,000 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The shares were acquired at an average cost of A$0.01 ($0.01) per share, with a total value of A$474,000.00 ($294,409.94).
James Garner also recently made the following trade(s):
- On Tuesday, December 24th, James Garner purchased 1,500,000 shares of Percheron Therapeutics stock. The shares were acquired at an average cost of A$0.01 ($0.00) per share, with a total value of A$10,500.00 ($6,521.74).
Percheron Therapeutics Price Performance
Percheron Therapeutics Company Profile
Featured Stories
- Five stocks we like better than Percheron Therapeutics
- What is the Euro STOXX 50 Index?
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- What Investors Need to Know to Beat the Market
- 5 Best Gold ETFs for March to Curb Recession Fears
- Insider Buying Explained: What Investors Need to Know
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
